Fraunhofer IPMS partners with MaxQ Medical to engineer capacitive micromachined ultrasonic transducers for minimally invasive prostate therapy.

BMDNow analyzes existing CT scans to calculate vertebral bone density, identifying osteoporosis and osteopenia without additional specialized examinations.

Fraunhofer IKTS develops specialized dressings designed to address chronic wounds, improve healing outcomes and offer new approaches to infection prevention.

PhysioINK uses collagen, elastin and cellulose derivatives to create printable bioinks for tissue models, drug development and future regenerative medicine.

Adaptive optics technology uses 64,000 movable mirrors to correct light scattering, enabling higher-contrast microscopy across biological samples and future medical diagnostics.

By integrating highly efficient thermoelectric materials into CMOS-compatible manufacturing technology for the first time, the project aims to create significantly more powerful sensors.

Fraunhofer developed the RNAuto platform to help pharmaceutical developers scale mRNA-based drug production while integrating quality control into the manufacturing process.

LiFi-based optical transmission using modulated LED light enables low-latency, high-bandwidth communication in operating room environments.

From April 21 to 23, in Berlin, the Fraunhofer-Gesellschaft will present advanced AI solutions and data-driven technologies designed to enhance medical decision-making and streamline healthcare documentation.

Fraunhofer researchers are developing an interactive assistance system to improve female mortality rates after cardiac events by integrating biosensors and AI-based history recording.